Taysha Gene Therapies, Inc. (TSHA): 8-K filed May 6, 2026

Form type
8-K
Filing date
May 6, 2026
Accession number
0001193125-26-207633
Filer
Taysha Gene Therapies, Inc. (CIK 1806310)